Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

German Multicenter EPO Stroke Trial (Phase II/III)

NCT00604630 is registered in ClinicalTrials.gov with Max-Planck-Institute of Experimental Medicine as lead sponsor.

NCT NCT00604630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00604630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
German Multicenter EPO Stroke Trial (Phase II/III)
Lead sponsor
Max-Planck-Institute of Experimental Medicine
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2003
Completion date
June 30, 2008
Enrollment
522 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

infarction, middle cerebral artery, middle cerebral artery stroke, stroke, acute